<VariationArchive RecordType="classified" VariationID="692074" VariationName="NM_005859.5(PURA):c.424dup (p.Ala142fs)" VariationType="Duplication" Accession="VCV000692074" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2019-10-20" MostRecentSubmission="2019-10-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="679745" VariationID="692074">
      <GeneList>
        <Gene Symbol="LOC129994826" FullName="ATAC-STARR-seq lymphoblastoid active region 23260" GeneID="129994826" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114557" stop="140114626" display_start="140114557" display_stop="140114626" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PURA" FullName="purine rich element binding protein A" GeneID="5813" HGNC_ID="HGNC:9701" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>5q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114109" stop="140125619" display_start="140114109" display_stop="140125619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139493707" stop="139499000" display_start="139493707" display_stop="139499000" Strand="+" />
          </Location>
          <OMIM>600473</OMIM>
          <Haploinsufficiency last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-06-07" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PURA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005859.5(PURA):c.424dup (p.Ala142fs)</Name>
      <CanonicalSPDI>NC_000005.10:140114602:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="140114602" stop="140114603" display_start="140114602" display_stop="140114603" variantLength="1" positionVCF="140114602" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="139494187" stop="139494188" display_start="139494187" display_stop="139494188" variantLength="1" positionVCF="139494187" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>A142fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.140114605dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.140114605dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.139494190dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.139494190dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041813.1" sequenceAccession="NG_041813" sequenceVersion="1" change="g.5483dup">
            <Expression>NG_041813.1:g.5483dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005859.5" sequenceAccession="NM_005859" sequenceVersion="5" change="c.424dup" MANESelect="true">
            <Expression>NM_005859.5:c.424dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005850.1" sequenceAccession="NP_005850" sequenceVersion="1" change="p.Ala142fs">
            <Expression>NP_005850.1:p.Ala142fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1581036383" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005859.5(PURA):c.424dup (p.Ala142fs) AND PURA Syndrome" Accession="RCV000853376" Version="1">
        <ClassifiedConditionList TraitSetID="51006">
          <ClassifiedCondition DB="MedGen" ID="C4708498">PURA Syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-10-20" MostRecentSubmission="2019-10-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="51006" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42997" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PURA Syndrome</ElementValue>
                <XRef ID="320566" DB="GeneTests" />
              </Name>
              <XRef ID="C4708498" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1954800" SubmissionDate="2019-09-20" DateLastUpdated="2019-10-20" DateCreated="2019-10-20">
        <ClinVarSubmissionID localKey="c.424dup" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000996247" DateUpdated="2019-10-20" DateCreated="2019-10-20" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 1 of 1 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function. This variant has not been previously reported or functionally characterized in the literature to our knowledge. Loss of function variants are established as a mechanism for disease in the PURA gene (PMID: 29150892). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. Based on the available evidence, the c.424dup, p.Ala142GlyfsTer59 variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">85</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PURA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005859.4:c.424dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PURA Syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6324741</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1954800" TraitType="Disease" MappingType="Name" MappingValue="PURA Syndrome" MappingRef="Preferred">
        <MedGen CUI="C4708498" Name="PURA Syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

